Literature DB >> 6849119

Relation between plasma and cerebrospinal fluid levels of 3-methoxy-4-hydroxyphenylglycol.

I J Kopin, E K Gordon, D C Jimerson, R J Polinsky.   

Abstract

Concentrations of free 3-methoxy-4-hydroxyphenylglycol in the plasma and cerebrospinal fluid are highly correlated, but concentrations in the cerebrospinal fluid are always higher than those in plasma, even when large amounts of the catecholamine metabolite are derived from a tumor of the adrenal medulla. This is explained by considering the plasma and cerebrospinal fluid as a two-compartment system in which the rate constants for entry into and exit from the cerebrospinal fluid compartment are similar. 3-Methoxy-4-hydroxyphenylglycol that is synthesized, but not catabolized, in the central nervous system maintains cerebrospinal fluid levels at an increment over those in plasma. This increment can be used to provide the best available index of formation of 3-methoxy-4-hydroxyphenylglycol in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6849119     DOI: 10.1126/science.6849119

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  15 in total

1.  The effect of clonidine on plasma MHPG: evidence against tonic alpha 2-adrenoceptor control of noradrenergic function.

Authors:  D J Nutt; S G Molyneux
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  Decrease in plasma levels of 3,4-dihydroxyphenylethyleneglycol in major depression.

Authors:  B Scatton; H Loo; T Dennis; C Benkelfat; C Gay; M F Poirier-Littre
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  Neurotransmitter markers in the cerebrospinal fluid of normal subjects. Effects of aging and other confounding factors.

Authors:  P Hartikainen; H Soininen; K J Reinikainen; J Sirviö; R Soikkeli; P J Riekkinen
Journal:  J Neural Transm Gen Sect       Date:  1991

4.  Raised plasma concentrations of 3-methoxy-4-hydroxyphenylethyleneglycol in cirrhotic patients with or without hepatic encephalopathy.

Authors:  H Echizen; A Minegishi; S Hayashi; N Umeda; T Oda; T Ishizaki
Journal:  Gut       Date:  1989-05       Impact factor: 23.059

5.  Lack of circadian rhythm in plasma levels of 3,4-dihydroxyphenylethyleneglycol in healthy human subjects.

Authors:  T Dennis; C Benkelfat; Y Touitou; A Auzeby; M F Poirier; B Scatton; H Lôo
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

6.  Developmental change of dopamine beta-hydroxylase activity in cerebrospinal fluid of epileptic and non-epileptic children.

Authors:  H Suzuki; M Shimohira; Y Iwakawa; T Nagatsu
Journal:  J Neural Transm Gen Sect       Date:  1990

7.  Relationships between clinical effects and monoamine metabolites and amino acids in sulpiride-treated schizophrenic patients.

Authors:  G Alfredsson; F A Wiesel
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

8.  Dose-dependent effects of deprenyl on CSF monoamine metabolites in patients with Alzheimer's disease.

Authors:  T Sunderland; P N Tariot; R M Cohen; P A Newhouse; A M Mellow; E A Mueller; D L Murphy
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

9.  Monoamine metabolites and amino acids in serum from schizophrenic patients before and during sulpiride treatment.

Authors:  G Alfredsson; F A Wiesel
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

10.  On the significance of monoamines and their metabolites in the cerebrospinal fluid of the sheep.

Authors:  M Ruckebusch; J F Sutra
Journal:  J Physiol       Date:  1984-03       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.